Generic cancer drugs are still in short supply

Generic cancer drugs are still in short supply - Nelson - 2024

The ongoing shortage has forced hospitals to continue rationing drugs and prompted new calls for federal investment and long-term solutions.

Chemotherapy Drug Shortage: What You Need to Know

You may have even seen scary headlines in 2023 about the record-high shortage of essential chemotherapy medicines. This included carboplatin and ...

US cancer centers warn drug shortages continue, impacting different ...

The centers that participated in the survey also reported that several other key cancer medications are currently in short supply, with 46% ...

Cancer Drug Shortage: Causes, Trends, and Implications for Clinical ...

Primary causes of the cancer drug shortage include manufacturing issues, supply chain disruptions, and regulatory delays.

Cancer Drug Shortages Happen, but No Cause for Alarm

The treatments most affected by the shortage include platinum-based injectable drugs, carboplatin and cisplatin, which are used to treat breast ...

Strengthening the supply chain for cancer drugs | OSTP

Unfortunately, the United States is currently experiencing a shortage of 15 cancer drugs due to manufacturing and supply chain issues. Three of ...

Generic cancer drugs are still in short supply - PubMed

Generic cancer drugs are still in short supply: The ongoing shortage has forced hospitals to continue rationing drugs and prompted new calls for federal ...

Drug Shortages Are Affecting Cancer Treatments | Johns Hopkins

Hundreds of medications are in shortage in the U.S., but a lack of chemotherapy drugs has left clinicians facing new hurdles in their ...

Generic Drug Shortages and Essential Cancer Medicines

We also present a few stopgap methods for dealing with the problem and a more comprehensive proposal for the allocation of generic chemotherapy ...

Shortage of Cancer Drugs is Killing American Children

The decline in prices for generic products – such as the cancer products currently in shortage, has been acute. In fact, in the past five ...

US cancer centers still see 'widespread' shortages of life-saving ...

US cancer centers still see 'widespread' shortages of life-saving chemo drugs, survey finds ... A cancer patient holds the IV tubes during ...

Coming Up Short: How Cancer Drug Shortages Affect Care

In many ways, the Pluvicto shortage was difficult to predict. However, as long as the pressure to produce older generic drugs at the lowest ...

Behind the Shortage Keeping Cancer Patients From Chemo

Intas recently resumed production, but the F.D.A. still lists the drugs as being in short supply. Major cancer centers report that the shortages ...

Cancer Drug Shortages Persist, Increasing Calls for Action

However, all 3 drugs were still in short supply at many cancer centers last month, according to a National Comprehensive Cancer Network (NCCN) ...

Drug Shortages - FDA

When a shortage is listed as current on the Drug Shortage Database, the FDA is aware of the supply situation and is working with the ...

Cancer Drug Shortages Continue in the US, Survey Finds - Medscape

"Many drugs that are currently in shortage form the backbones of effective multiagent regimens across both curative and palliative treatment ...

Chemotherapy drug shortage eases slightly but still widespread

Shortages have been acute and widespread this year, but doctors told STAT they're nothing new. The economics of drug development make generic ...

Shortage on 4 cancer drugs creates dire scenarios for patients

FDA says there are shortages of four cancer drugs — Pluvicto, methotrexate, cisplatin and fluorouracil — forcing patients and doctors to ...

Recent shortage of cancer drugs leaves patients around the world ...

The recent, abrupt shortage of critical cancer drugs highlights a broken business model in generic drugs that leaves patients in the US and all over the world ...

Why There's a Serious Cancer Drug Shortage, and How to Fix It

The recent national shortage in chemotherapy drugs points to a need to overhaul the generics market.